Home/Filings/3/0001104659-21-112196
3//SEC Filing

FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ 3

Accession 0001104659-21-112196

CIK 0001818382operating

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 6:05 AM ET

Size

5.0 KB

Accession

0001104659-21-112196

Insider Transaction Report

Form 3
Period: 2021-08-26
Holdings
  • Common Stock, par value $0.0001 per share

    18,312,735
Footnotes (2)
  • [F1]Excludes the Reporting Person's pro rata share of up to 15,000,000 additional shares of the Issuer's Common Stock which may become issuable to the former shareholders of Humacyte, Inc. pursuant to the terms of the Business Combination Agreement dated as of February 17, 2021 by and among the Issuer, Hunter Merger Sub, Inc. and Humacyte, Inc., as to which the Reporting Person disclaims any present beneficial ownership interest.
  • [F2]Fresenius Medical Care Holdings, Inc. is an indirect, wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA ("FMC AG & Co. KGaA"). FMC AG & Co. KGaA's address is Else-Kroner Strasse 1, 61352 Bad Homburg, Germany.

Documents

1 file

Issuer

Humacyte, Inc.

CIK 0001818382

Entity typeoperating
IncorporatedNY

Related Parties

1
  • filerCIK 0000042872

Filing Metadata

Form type
3
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 6:05 AM ET
Size
5.0 KB